SEC 13F Intelligence

North Peak Capital Management, LLC / HAE

North Peak Capital Management, LLC’s Haemonetics Corp Mass Position

Does North Peak Capital Management, LLC own Haemonetics Corp Mass (HAE)? Yes999.0K shares worth $56M (+9.36% of its 13F portfolio) as of Q1 2026, down from 1.10M shares the prior filed quarter.

Position Value
$56M
Q1 2026
Shares
999.0K
% of Portfolio
+9.36%
Quarters Held
3
currently held

Position History HAE

Reported value by quarter
Q3 ’25: $18MQ3 ’25Q4 ’25: $88MQ4 ’25Q1 ’26: $56MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026999.0K$56M+9.36%
Q4 20251.10M$88M+7.51%
Q3 2025362.4K$18M+1.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See North Peak Capital Management, LLC’s full portfolio or all institutional holders of HAE.